Automated Benchtop System Prepares Samples for the Roche GS FLX DNA Sequencer

DANVERS, Mass. – Beckman Coulter Genomics introduces the SPRIworks Fragment Library System II. The second release in the SPRIworks product line automates the preparation of fragment libraries for the Roche GS FLX* DNA Sequencer, and can prepare up to 10 DNA libraries in 3.5 hours with high reproducibility and consistency.

SPRIworks Fragment Library System II, developed by Beckman Coulter Genomics, utilizes Solid Phase Reversible Immobilization (SPRI) paramagnetic bead-based technology. By using SPRI chemistry and Beckman Coulter automation, SPRIworks System II eliminates manual library construction, allowing researchers to perform other laboratory processes.

SPRIworks System II follows the introduction earlier this year of SPRIworks System I, which prepares DNA fragment libraries for analysis on the Illumina GA sequencing system. SPRIworks Fragment Library Systems I and II are based on the same benchtop platform. By using cartridges and method cards specific to each sequencing system, fragment libraries can be prepared for both the Roche GS FLX and Illumina GA sequencers on a single instrument.

“The introduction of SPRIworks System II enables us to more fully serve customers who use DNA fragment libraries,” commented Julie Moore, director of marketing for Beckman Coulter Genomics. “Automating the library construction process for these two leading sequencing platforms offers significant time and labor savings by simplifying the next generation sequencing workflow.”

About Beckman Coulter Genomics

Beckman Coulter Genomics, headquartered in Danvers, Massachusetts, is a leading provider of genomic services and nucleic acid purification products, serving life-science researchers and the pharmaceutical industry throughout the world. The company, a wholly owned subsidiary of Beckman Coulter, was created by combining Beckman Coulter’s Agencourt Bioscience with the newly acquired Cogenics. By providing technical expertise, combined with personalized service, Beckman Coulter Genomics delivers the highest quality data, robust analyses and innovative thinking. For more information, visit www.beckmangenomics.com.

About Beckman Coulter, Inc.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represent about 80 percent of the company’s 2009 revenue of $3.3 billion. For more information, visit www.beckmancoulter.com.

*GS FLX is a trademark of Roche.

Beckman Coulter, SPRI, Agencourt and the stylized logo are registered trademarks of Beckman Coulter, Inc